Login / Signup

A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects.

Alina SadafMin DongAmanda PfeifferTeresa LathamTheodosia KalfaAlexander A VinksRussell E WareCharles T Quinn
Published in: Clinical pharmacokinetics (2024)
This trial is registered at ClinicalTrials.gov (NCT04684381).
Keyphrases
  • sickle cell disease
  • study protocol
  • clinical trial
  • phase iii
  • phase ii
  • human health
  • risk assessment
  • open label
  • climate change